Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention
Chuanhao Xiong,1,* Jingzhu Wu,1,* Yuhang Ma,1,* Na Li,1 Xuejiao Wang,1 Yao Li,2 Xiaoying Ding1 1Department of Endocrinology and Metabolism, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Department of Labora...
Main Authors: | Xiong C, Wu J, Ma Y, Li N, Wang X, Li Y, Ding X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-02-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Subjects: | |
Online Access: | https://www.dovepress.com/effects-of-glucagon-like-peptide-1-receptor-agonists-on-gut-microbiota-peer-reviewed-fulltext-article-DMSO |
Similar Items
-
Effect of glucagon-like peptide-1 (GLP-1) agonists on the example of semaglutide on the cardiovascular system and their role in the treatment of obesity.
by: Kamil Pondel, et al.
Published: (2022-08-01) -
Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
by: Signe Frøssing, et al.
Published: (2018-01-01) -
Agonist hold Antagonist Protocol versus Antagonist Protocol in Intracytoplasmic Sperm Injection for Infertile Patients with Polycystic Ovary Syndrome
by: Hazem H. Ahmed, et al.
Published: (2022-01-01) -
Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives
by: Mojca Jensterle, et al.
Published: (2022-08-01) -
The Discovery and Development of Liraglutide and Semaglutide
by: Lotte Bjerre Knudsen, et al.
Published: (2019-04-01)